Pembrolizumab for advanced melanoma

In final draft guidance, NICE has recommended that pembrolizumab should be made available on the NHS for some adult patients with advanced melanoma which is either unresectable or metastatic

Sign in to continue

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us



  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package